Evidence map›Paper›PMID 20535134›Full record

ArticleGenes and immunity2010

Evidence for associations between the purinergic receptor P2X(7) (P2RX7) and toxoplasmosis.

S E Jamieson, A L Peixoto-Rangel, A C Hargrave, L-A de Roubaix, E J Mui, N R Boulter, E N Miller, S J Fuller, J S Wiley, L Castellucci and 21 more

Open access · greenAbstract read
In one paragraph

Article in Genes and immunity, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it, 102 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. P2RX7 at the Host-Pathogen Interface of Infectious Diseases.Microbiology and molecular biology reviews : MMBR · 2021
    Review
  15. Article
  16. Article
  17. Toxoplasmosis in Germany.Deutsches Arzteblatt international · 2019
    Review
  18. Article
  19. Enzyme-Linked Aptamer Assay (ELAA) for Detection ofFrontiers in cellular and infection microbiology · 2019
    Article
  20. Influence of Two MajorFrontiers in cellular and infection microbiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 9 institutions in 4 countries.

S E JamiesonCambridge Institute for Medical Research and Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge, UK.
A L Peixoto-Rangel
A C Hargrave
L-A de Roubaix
E J Mui
N R Boulter
E N Miller
S J Fuller
J S Wiley
L Castellucci
K Boyer
R G Peixe
M J Kirisits
L de Souza Elias
J J Coyne
R Correa-Oliveira
M Sautter
N C Smith
M P Lees
C N Swisher
P Heydemann
A G Noble
D Patel
D Bardo
D Burrowes
D McLone
N Roizen
S Withers
L M G Bahia-Oliveira
R McLeod
J M Blackwell
University of Chicago · USUniversity of Cambridge · GBState University of Norte Fluminense · BRUniversity of Technology Sydney · AUBoston Children's Hospital · USFundação Oswaldo Cruz · BRRush University Medical Center · USNepean Hospital · AUUniversity of Sydney · AU

Funding

TREATMENT OF CONGENITAL TOXOPLASMOSISR01AI027530 · NIAID · UNIVERSITY OF CHICAGO · PI MCLEOD, RIMA L · 1989 to 2010
$2.8M
Innate Immune Receptors for Toxoplasma gondiiR01AI071319 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GAZZINELLI, RICARDO TOSTES · 2006 to 2010
$2.7M
NOVEL APICOMPLEXAN METABOLISM AND ORGANELLE TRANSITR01AI043228 · NIAID · UNIVERSITY OF CHICAGO · PI MCLEOD, RIMA L · 1997 to 2005
$2.1M
IMMUNE RESPONSE TO INGESTED TOXOPLASMAR01AI016945 · NIAID · UNIVERSITY OF CHICAGO · PI MCLEOD, RIMA L · 1985 to 1997
–
NIAID NIH HHS R01 AI016945NIAID NIH HHS R01 AI027530NIAID NIH HHS R01 AI043228NIAID NIH HHS R01 AI071319PHS HHS 071319-01PHS HHS 16945 01-20PHS HHS 27530 01-20PHS HHS 4328 01-11
6 · The paper itself

Abstract

Congenital Toxoplasma gondii infection can result in intracranial calcification, hydrocephalus and retinochoroiditis. Acquired infection is commonly associated with ocular disease. Pathology is characterized by strong proinflammatory responses. Ligation of ATP by purinergic receptor P2X(7), encoded by P2RX7, stimulates proinflammatory cytokines and can lead directly to killing of intracellular pathogens. To determine whether P2X(7) has a role in susceptibility to congenital toxoplasmosis, we examined polymorphisms at P2RX7 in 149 child/parent trios from North America. We found association (FBAT Z-scores +/-2.429; P=0.015) between the derived C(+)G(-) allele (f=0.68; OR=2.06; 95% CI: 1.14-3.75) at single-nucleotide polymorphism (SNP) rs1718119 (1068T>C; Thr-348-Ala), and a second synonymous variant rs1621388 in linkage disequilibrium with it, and clinical signs of disease per se. Analysis of clinical subgroups showed no association with hydrocephalus, with effect sizes for associations with retinal disease and brain calcifications enhanced (OR=3.0-4.25; 0.004<P<0.009) when hydrocephalus was removed from the analysis. Association with toxoplasmic retinochoroiditis was replicated (FBAT Z-scores +/-3.089; P=0.002) in a small family-based study (60 families; 68 affected offspring) of acquired infection in Brazil, where the ancestral T(+) allele (f=0.296) at SNP rs1718119 was strongly protective (OR=0.27; 95% CI: 0.09-0.80).

Indexed as

AdultBrazilChild, PreschoolChorioretinitisFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyHaplotypesHumansInheritance PatternsLinkage DisequilibriumLogistic ModelsMaleNorth AmericaPolymorphism, Single NucleotideReceptors, Purinergic P2P2RX7 protein, humanReceptors, Purinergic P2Receptors, Purinergic P2X7

Identifiers

PMID20535134
PMCPMC2908187
OpenAlexW2043464754

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.